symtuza
janssen-cilag international nv - darunavir, cobicistat, emtricitabine, tenofovir alafenamide - hiv infekcijas - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - symtuza indicēts cilvēka imūndeficīta vīrusa 1. tipa (hiv-1) infekcijas ārstēšanai pieaugušajiem un pusaudžiem (no 12 gadu vecuma un vecākiem ar ķermeņa svaru vismaz 40 kg). genotypic testing should guide the use of symtuza.
tremfya
janssen-cilag international nv - guselkumabs - psoriāze - imūnsupresanti - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
dailyal 500 mg tabletes
genmed b.v., netherlands - paracetamols - tablete - 500 mg
metfogamma 1000 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - metformīna hidrohlorīds - apvalkotā tablete - 1000 mg
sortis 40 mg apvalkotās tabletes
upjohn eesv, netherlands - atorvastatīns - apvalkotā tablete - 40 mg
sortis 10 mg apvalkotās tabletes
upjohn eesv, netherlands - atorvastatīns - apvalkotā tablete - 10 mg
sortis 20 mg apvalkotās tabletes
upjohn eesv, netherlands - atorvastatīns - apvalkotā tablete - 20 mg
sortis 80 mg apvalkotās tabletes
upjohn eesv, netherlands - atorvastatīns - apvalkotā tablete - 80 mg
gabagamma 400 mg cietās kapsulas
wörwag pharma gmbh & co.kg, germany - gabapentīns - kapsula, cietā - 400 mg
metfogamma 850 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - metformīna hidrohlorīds - apvalkotā tablete - 850 mg